# CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
> **ANDA212367** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2020-09-11
## Drug
- **FDA Application Number:** ANDA212367
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
- **Generic name:** Betamethasone Dipropionate
- **Active ingredients:** BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- **Dosage form:** SUSPENSION
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** PADAGIS ISRAEL
- **First approval:** 2020-09-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212367)
---
*AI Analytics · CC0 1.0*